- Home
- PLUG vs SRPT Comparison
PLUG vs SRPT Comparison
Compare PLUG & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLUG | SRPT |
|---|---|---|
| Founded | 1997 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 1999 | 1997 |
Fundamental Metrics
Financial Performance| Metric | PLUG | SRPT |
|---|---|---|
| Price | $2.20 | $21.71 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 13 | 29 |
| Target Price | $2.11 | ★ $26.23 |
| AVG Volume (30 Days) | ★ 92.8M | 2.9M |
| Earning Date | 11-10-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $676,169,000.00 | ★ $2,413,715,000.00 |
| Revenue This Year | $13.86 | $13.72 |
| Revenue Next Year | $21.99 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.53 | ★ 47.15 |
| 52 Week Low | $0.69 | $10.42 |
| 52 Week High | $4.58 | $129.84 |
Technical Indicators
Market Signals| Indicator | PLUG | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 51.93 | 53.57 |
| Support Level | $1.92 | $21.33 |
| Resistance Level | $2.14 | $22.52 |
| Average True Range (ATR) | 0.16 | 0.92 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 52.72 | 55.87 |
Price Performance
Historical ComparisonAbout PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.